View Post

AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

In Clinical Trials by Barbara Jacoby

Source: AIVITA Biomedical, Inc. From: AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial. The patient has received the eighth and final dose of the study therapy under the guidance of Principal Investigator Dr. Lisa Abaid …